In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including Medicare Part D impacts from the Inflation Reduction Act, Novo Nordisk’s cuts to insulin prices, and the PBM Transparency Act of 2023.
Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, Medicare, drug prices, PBMs
Source Links:
- True catastrophic coverage and shifting liability: Preparing for IRA changes
- Inflation Reduction Act: What health plans and Part D sponsors need to know to be prepared
- Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US
- Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.
- Senate panel advances bill to reform PBMs and bring more FTC scrutiny on industry
- Commerce Committee Approves Cantwell, Grassley Bipartisan Bill to Combat Rising Prescription Drug Prices
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Ryan Hummel, Executive and Head of Provider Sector
Jen Burke, Healthcare Industry Strategist
You Might Like
